Your browser doesn't support javascript.
loading
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors.
Tsimberidou, Apostolia M; Beer, Philip A; Cartwright, Carrie A; Haymaker, Cara; Vo, Henry H; Kiany, Simin; Cecil, Alexander R L; Dow, James; Haque, Kemal; Silva, Franck A; Coe, Lucy; Berryman, Helen; Bone, Elisabeth A; Nogueras-Gonzalez, Graciela M; Vining, David; McElwaine-Johnn, Hilary; Wistuba, Ignacio I.
Afiliación
  • Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, Texas. atsimber@mdanderson.org p.beer@karustherapeutics.com.
  • Beer PA; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom. atsimber@mdanderson.org p.beer@karustherapeutics.com.
  • Cartwright CA; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Haymaker C; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vo HH; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kiany S; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cecil ARL; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Dow J; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Haque K; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Silva FA; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Coe L; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Berryman H; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Bone EA; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Nogueras-Gonzalez GM; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vining D; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McElwaine-Johnn H; Karus Therapeutics LTD, Oxfordshire, England, United Kingdom.
  • Wistuba II; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 27(13): 3584-3594, 2021 07 01.
Article en En | MEDLINE | ID: mdl-33947698
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Histona Desacetilasas / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Histona Desacetilasas / Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article